<G> If you had Genset and Targeted Genetics
in your basket of disasters, you would be
pretty timid too, heheh!
Say, while I have you here, following up on
that last post of mine (tropix screeening).
Just off the top of your head, would you say
that the license is likely to be a particularly
useful thing for Rigel:
Helen Blau - Licensed Technology
Rossi, F., Charlton, C.A. and Blau, H.M. (1997). Monitoring protein-protein interactions in intact eukaryotic cells by b-galactosidase complementation. Proc. Natl Acad Sci USA, 94:8405-10.
Mohler, W. A. and Blau, H. M. (1996). Gene expression and cell fusion analyzed by lacZ complementation in mammalian cells. Proc Natl Acad Sci USA, 93:12423-7.
<proteomic companies>
Dancing in and out of a very small position in LSBC.
I bought my 3000 shares back last week around $2.8. |
